Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics…of Peptides and P-ANDAS by Annie De Groot | Oct 30, 2018EpiVax_EuroTIDES_PANDA_02Nov18 To learn more about EpiVax’s PANDA Program, read our latest entries. PANDA screening Interview with Brian Roberts: Protein Therapeutics Manager PANDA Press Release
HLA Binding Assay Design: Impact of HLA binding motif centering on HLA binding results and T cell response; Relevance to Overlapping Peptide Analysis by Annie De Groot | Oct 5, 2018